Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05171062
What this trial is testing

Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The University of Texas Health Science Center at San Antonio
Early research (Phase 1)Study completedNCT06525246
What this trial is testing

Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+2 more
Ono Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Not applicableStudy completedNCT01004601
What this trial is testing

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Chang Gung Memorial Hospital 179
Testing effectiveness (Phase 2)UnknownNCT02669719
What this trial is testing

Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Chest Hospital 70
Early research (Phase 1)Study completedNCT00503568
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy

Who this might be right for
Lung Cancer
University of Miami 19
Large-scale testing (Phase 3)Ended earlyNCT00473889
What this trial is testing

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Who this might be right for
Stage IIIB or IV Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 253
Not applicableUnknownNCT04636775
What this trial is testing

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Jun Zhang, MD, PhD 46
Large-scale testing (Phase 3)Active Not RecruitingNCT04143607
What this trial is testing

ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 337
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)UnknownNCT03987087
What this trial is testing

Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC

Who this might be right for
Malignant Pleural EffusionNonsmall Cell Lung Cancer, Stage IV
Guizhou Medical University 68
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Large-scale testing (Phase 3)Study completedNCT02031744
What this trial is testing

The Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 530
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647
What this trial is testing

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more
SWOG Cancer Research Network 116
Large-scale testing (Phase 3)UnknownNCT05104281
What this trial is testing

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 60
Early research (Phase 1)Study completedNCT00866528
What this trial is testing

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 30
Not applicableStudy completedNCT00823732
What this trial is testing

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
City of Hope Medical Center 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166487
What this trial is testing

Plasma-Adapted First-Line Pembro In NSCLC

Who this might be right for
NSCLC Stage IVMetastatic Non-Small Cell Lung Cancer
Julia K. Rotow, MD 40
Testing effectiveness (Phase 2)Ended earlyNCT02179567
What this trial is testing

Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC

Who this might be right for
NSCLC
Hellenic Oncology Research Group 26
Not applicableStudy completedNCT04154163
What this trial is testing

Appropriate Dosing to Optimise Personalised Cancer Treatments

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVOvarian Cancer+3 more
University of Dundee 18
Next Page